GPX4 and obesity due to melanocortin 4 receptor deficiency: Although we provide substantial evidence supporting the protective role of macrophage‐specific Gpx4 ablation in obesity‐induced insulin resistance and associated metabolic dysfunction, we did not determine whether inhibiting macrophage ferroptosis could reverse the beneficial effects of Gpx4 deletion in these conditions.